查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
雨生红球藻全球市场 - 2022-2029
市场调查报告书
商品编码
1169028

雨生红球藻全球市场 - 2022-2029

Global Haematococcus Pluvialis Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 97 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

雨生红球藻市场预计在预测期内（2022-2029 年）以 10.23% 的复合年增长率增长。

雨生红球藻广泛用于生产高价值最终产品的行业，例如食品和饮料、膳食补充剂、药品、油漆和颜料、肥料和燃料。 雨生红球藻含有脂质、藻类蛋白质、水胶体和其他成分，使其在製造最终产品时非常有用且备受追捧。 各种类型的微藻和海藻，包括蓝绿藻 (BGA)、红藻和褐藻，被用于製造释放有益营养素的实用产品。 绿藻雨生红球藻数量丰富、耐寒且价格低廉，在世界范围内经常用于生物製品。 它用于生产用于治疗糖尿病、多发性硬化症和癌症的药物、维生素、疫苗、膳食补充剂和其他营养素。 雨生红球藻在养殖鱼类和其他养殖牲畜生产中的应用扩大了市场。

市场动态：膳食补充剂中对天然虾青素的需求不断增长推动市场扩张

虾青素的一个潜在来源是雨生红球藻微藻。 它是一种类胡萝卜素，在红色生长阶段会积累颜色并起到抗氧化剂的作用。 藻类来源的虾青素经常被用作药物，因为它具有增强的抗氧化活性和潜在的治疗效果。 最近的研究证实，这种鲜红色的类胡萝卜素可以清除自由基并减少氧化应激，表明这种作用有益于心血管健康、体力消耗后的恢復以及皮肤和关节健康。它是

另一方面，由于慢性病的增加和人们生活方式的改变，全球范围内保健食品和营养补充剂的消费量显着增加。 这是影响市场扩张的最重要因素之一。 雨生红球藻也经常用于去除或转化废水中的污染物，例如营养物、重金属和异生素。

然而，高生产成本和气候对雨生红球藻的影响预计将减缓市场增长速度。 此外，食用基于藻类的处方药产品（如小球藻、太阳能微藻和螺旋藻）会导致胃肠道、腹部和噁心症状。 该问题将限制雨生红球藻整体市场的拓展。 此外，在整个预测期内，由于新兴国家的研发活动和意识低下，雨生红球藻市场将面临挑战。

市场细分：虾青素大宗成品细分市场全球雨生红球藻占比最高

许多微藻类、酵母菌和细菌都含有类胡萝卜素色素虾青素。 雨生红球藻是一种绿色微藻，在压力下（例如营养缺乏或暴露于强光下）会产生大量虾青素。 当红球藻细胞受损时，释放的虾青素可用作营养补充剂、功能性食品和饮料、化妆品和药物的成分。

另一方面，虾青素是一种天然存在的类胡萝卜素色素，作为叶黄素的一员，市场有望扩大。 它存在于藻类和水生生物中，例如鲑鱼、鳟鱼、磷虾、虾和龙虾。 虾青素赋予这些生物粉红色和红色。 雨生红球藻是一种微藻，是虾青素的主要商业来源。

地理渗透：北美将成为预测期内的主导区域

北美预计在预测期内会增长。 北美的很大一部分主要是由于消费者对化学产品的负面影响的认识不断提高以及对天然食品补充剂的需求不断增加。 此外，预计不同组织开展的几项宣传活动将增加该地区的市场份额。 例如，天然藻类虾青素协会 (NAXA) 致力于传播有关虾青素消费的知识。 雨生红球藻在美国和加拿大也被允许用作膳食补充剂的成分，这是影响北美物种扩张的另一个重要因素。

另一方面，由于健康意识的提高、食品饮料和保健品行业的扩张、对个人护理产品的巨大需求以及高投资，预计亚太地区在预测期内将以最快的复合年增长率增长在藻类生产中。预期。 此外，亚洲国家政府对藻类生产的支持不断增加，为该地区的各种市场参与者提供了巨大的机会。

内容

第1章调查方法及范围

  • 调查方法
  • 市场范围

第2章主要趋势与发展

第 3 章执行摘要

  • 按类型细分的市场
  • 按应用划分的市场细分
  • 按地区划分的市场细分

第4章市场动态

  • 市场影响因素
    • 司机
    • 约束因素
    • 商机
  • 影响分析

第5章行业分析

  • 波特的五力分析
  • 价值链分析
  • 专利分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措

第 7 章按类型

  • 虾青素原料
  • 虾青素活性成分成品

第 8 章应用

  • 食物和饮料
  • 营养保健品
  • 医药
  • 化妆品
  • 动物饲料

第9章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第10章竞争格局

  • 竞争场景
  • 竞争战略分析
  • 市场情况/份额分析
  • 併购分析

第11章公司简介

  • 氰技术公司
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • E.I.D. Parry
  • BlueBioTech
  • Algae to Omega
  • Tianjin Norland Biotech
  • AlgaeCan Biotech
  • AstaReal AB
  • Yunnan Alphy Biotech
  • Pond Technologies
  • Fenchem

第12章 DataM

简介目录
Product Code: DMFB6038

Market Overview

Haematococcus Pluvialis Market was valued at USD YY million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of 10.23% during the forecast period (2022-2029)

Haematococcus Pluvialis is used in a wide range of industries to produce high-value end products, including food and drink, nutraceuticals, pharmaceuticals, paints and colorants, fertilizer, and fuel. Haematococcus Pluvialis is useful and highly demanded in making finished products because of its lipids, algal proteins, hydrocolloids, and other components. The various types of microalgae or seaweed, including blue-green algae (BGA), red algae, and brown algae, are used to make practical products that are bursting with beneficial nutrients. Because it is plentiful, hardy, and affordable, green haematococcus pluvialis is frequently used in biological medications worldwide. For the treatment of diabetes, multiple sclerosis, and cancer, they are used in the production of pharmaceuticals, vitamins, vaccines, nutraceuticals, and other nutrients. Adopting haematococcus pluvialis to produce fish for cultivation and other livestock for aquaculture varieties is growing the market.

Market Dynamics: Growing demand for natural astaxanthin in nutraceuticals drives market expansion

A potential source of astaxanthin is the microalga haematococcus pluvialis. It is a carotenoid that accumulates in color and is an antioxidant during the red growth phase. Due to its increased antioxidant activity and therapeutic potential, astaxanthin derived from algae is frequently used in pharmaceutical applications. Recent studies have confirmed the vibrant red carotenoid's capacity to snuff out free radicals and lessen oxidative stress, correlating this action with benefits for cardiovascular health, recovery from physical exertion, and skin and joint health.

On the other hand, the consumption of healthy food items and dietary supplements has significantly increased worldwide due to the rise in chronic disease prevalence and people's changing lifestyles. One of the most important elements affecting market expansion is this. In addition, haematococcus pluvialis is frequently used to remove and transform pollutants from wastewater, including nutrients, heavy metals, and xenobiotics.

However, the market's growth rate will be slowed by the high production cost and climate's effect on haematococcus pluvialision. Furthermore, the consumption of algae-based prescription medicine products like chlorella, sun microalgae, and spirulina brought gastrointestinal, abdominal, and nauseous symptoms. This issue will limit the market's overall expansion for haematococcus pluvialis. Throughout the forecast period, the haematococcus pluvialis market will also face difficulties due to a lack of R&D activities in developing nations and awareness.

Market Segmentation: Astaxanthin bulk finished products segment accounted for the highest share in global global haematococcus pluvialis

Numerous microalgae, yeast, and bacteria contain the carotenoid pigment astaxanthin. A green microalga called haematococcus pluvialis produces a lot of astaxanthin when under stress, like when it's starved of nutrients or exposed to intense light. The released astaxanthin can be used as an ingredient in dietary supplements, functional foods and beverages, cosmetics, and pharmaceuticals when haematococcin cells are damaged.

On the other hand, astaxanthin is expected to grow in the market as a carotenoid pigment found naturally and is a member of the xanthophyll family. Algae and aquatic creatures like salmon, trout, krill, shrimp, and lobster contain it. These organisms are pink or red because of astaxanthin. The microalga Haematococcus Pluvialis is the primary commercial source of astaxanthin.

Geographical Penetration: The North America is the dominating region during the forecast period

North America is expected to grow during the forecast period. A significant portion of North America is primarily attributed to rising consumer awareness of the negative effects of chemical products and rising demand for natural food supplements. Additionally, several awareness campaigns by different organizations are predicted to increase the regional market share. For instance, the Natural Algae Astaxanthin Association (NAXA) is committed to spreading knowledge about the consumption of astaxanthin. The fact that haematococcus pluvialis algae are permitted for use as a component in dietary supplements in the United States and Canada is another important factor influencing the species' expansion in North America.

On the other hand, due to rising health consciousness, the expansion of the food and beverage and nutraceutical industries, the enormous demand for personal care products, and high investment in algae production, the Asia Pacific region is anticipated to grow at the fastest CAGR during the forecast period. Additionally, the growing government support for algae production in Asian nations presents significant opportunities for the region's various market participants.

Competitive Landscape:

There are several established participants in the industry and local manufacturers; hence, the market is fragmented. Some major key players include Cyanotech Corporation, E.I.D. Parry, BlueBioTech, Algae to Omega, Tianjin Norland Biotech, AlgaeCan Biotech, AstaReal AB, Yunnan Alphy Biotech, Pond Technologies, Fenchem, and BDI-BioLife Science. During the forecast period, these are some key factors anticipated to propel the growth of the global haematococcus pluvialis market. For instance, in 2021, Lycored introduced in Branchburg, New Jersey, an oleoresin made from haematococcus pluvialis algae for soft gels and a microencapsulated starch beadlet, cold water dispersible microencapsulated solution for beverages, and dry mixes.

On the other hand, On July 27th, 2021 AstaReal, has launched NOVASTA, a pet food and feed ingredient rich in antioxidants, into the European market. On the other hand, on 2nd October 2020, Erber Group was purchased by Royal DSM for an enterprise value of €980 million. Royal DSM is a global science-based nutrition, health, and sustainable living company.

COVID-19 Impact: Positive impact on the global haematococcus pluvialis market

The abrupt COVID-19 pandemic outbreak prompted the implementation of strict lockdown regulations across many countries. In addition to dealing with the COVID-19 pandemic, the world is battling other health crises. The COVID-19 pandemic has had a significant impact on the haematococcus pluvialis market, emphasizing the significance of consumers' worldwide adopting secure, wholesome, and nutritive eating practices. A significant factor anticipated to fuel market growth is the preference of more health-conscious consumers for natural food coloring agents that have fewer side effects than other chemical products. As a result, the demand for the haematococcus pluvialis market has not affected by the universal pandemic.

The global haematococcus pluvialis market report would provide an access to approximately 53 market data tables, 44 figures and 97 pages.

Table of Contents

1. Scope and Methodology

  • 1.1. Research Methodology
  • 1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market impacting factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
  • 4.2. Impact analysis

5. Industry Analysis

  • 5.1. Porter's five forces analysis
  • 5.2. Value chain analysis
  • 5.3. Patent Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Type
    • 7.1.2. Market attractiveness index, By Type
  • 7.2. Astaxanthin Ingredients *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 7.3. Astaxanthin Bulk Finished Products

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Application
    • 8.1.2. Market attractiveness index, By Application
  • 8.2. Food and Beverage *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 8.3. Nutraceuticals
  • 8.4. Pharmaceuticals
  • 8.5. Cosmetics
  • 8.6. Animal Feeds

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key region-specific dynamics
    • 9.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Rest of South America
  • 9.4. Europe
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 9.4.5.1. Germany
      • 9.4.5.2. U.K.
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Italy
      • 9.4.5.6. Rest of Europe
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 9.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application

10. Competitive Landscape

  • 10.1. Competitive scenario
  • 10.2. Competitor strategy analysis
  • 10.3. Market positioning/share analysis
  • 10.4. Mergers and acquisitions analysis

11. Company Profiles

  • 11.1. Cyanotech Corporation *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. E.I.D. Parry
  • 11.3. BlueBioTech
  • 11.4. Algae to Omega
  • 11.5. Tianjin Norland Biotech
  • 11.6. AlgaeCan Biotech
  • 11.7. AstaReal AB
  • 11.8. Yunnan Alphy Biotech
  • 11.9. Pond Technologies
  • 11.10. Fenchem
  • List not Exhaustive*

12. DataM

  • 12.1. Appendix
  • 12.2. About us and services
  • 12.3. Contact us